FDA Approves Emergency Use of 2 Anti-Malaria Drugs to Treat CCP Virus

The U.S. FDA on March 28 issued an emergency use authorization for hydroxychloroquine and chloroquine to treat patients hospitalized with CCP virus.

The headquarters of the U.S. Food and Drug Administration (FDA) in Silver Spring, Maryland, on Nov. 4, 2009. Jason Reed/File Photo/Reuters

The U.S. Food and Drug Administration (FDA) on March 28 issued an emergency use authorization for hydroxychloroquine and chloroquine to treat patients hospitalized with the CCP virus.

The drugs, which are used to treat malaria, lupus, and rheumatoid arthritis, have been championed by President Donald Trump, who, at a White House briefing last week, said they had shown “very encouraging early results” and were a “game-changer” in the effort to combat the CCP (Chinese Communist Party) virus, commonly known as novel coronavirus.